Common use of Program Advisory Committee Clause in Contracts

Program Advisory Committee. The Parties recognize, because of the contributions made to the Program by NCATS as a result of the NIH Grant, that NCATS has an interest in the activities of the work under this Agreement. Accordingly, as provided in Section 1.2, nothing in this Agreement may be construed to conflict with or supersede the rights and requirements of the NIH under the terms and conditions of the NIH Grant or by operation of law or regulation. The Parties will establish a program advisory committee (the “Program Advisory Committee” or “PAC”) comprised of two (2) representatives, one from each of AMC and Pfizer (the “Contacts”), and up to four (4) additional members from each of AMC and Pfizer. The names of the initial Contacts for each of Pfizer and AMC are set out in Exhibit A. The PAC will: 4.1.1 review and make recommendations regarding changes to the Project Plan based on emerging data as requested by the NIH Grantee; 4.1.2 monitor and facilitate the timely progress of the Project Plan; 4.1.3 monitor and consider the protection of intellectual property arising from results of the Project Plan, as necessary, and specifically prior to public disclosures; 4.1.4 address such other matters relating to the activities of the Parties under this Agreement as either Party may bring before the PAC, including any matters that are expressly for the PAC to decide as provided in this Agreement; and 4.1.5 attempt to resolve any disputes on an informal basis. 4.1.6 align with and communicate with the steering committee of the NIH Grant.